These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 15389244

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial.
    Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kałmucki P, Kurpisz M.
    Eur Heart J; 2005 Jun; 26(12):1188-95. PubMed ID: 15764613
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment--report on two cases.
    Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Kałmucki P, Kurpisz M.
    Kardiol Pol; 2003 Dec; 59(12):492-501. PubMed ID: 14724696
    [Abstract] [Full Text] [Related]

  • 5. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
    Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA.
    Circulation; 2008 Mar 04; 117(9):1189-200. PubMed ID: 18285565
    [Abstract] [Full Text] [Related]

  • 6. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
    Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E.
    Circulation; 2005 Sep 20; 112(12):1748-55. PubMed ID: 16172284
    [Abstract] [Full Text] [Related]

  • 7. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.
    Menasché P, Hagège AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D.
    J Am Coll Cardiol; 2003 Apr 02; 41(7):1078-83. PubMed ID: 12679204
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.
    Rong SL, Lu YX, Liao YH, Wang XL, Wang YJ, Chang C, Wang YQ, Liu QY, Gao YZ, Mi SH.
    Chin Med J (Engl); 2008 Feb 20; 121(4):347-54. PubMed ID: 18304469
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA, Sawa Y, Miyagawa S, Taketani S, Matsuda H.
    J Thorac Cardiovasc Surg; 2005 Sep 20; 130(3):646-53. PubMed ID: 16153908
    [Abstract] [Full Text] [Related]

  • 13. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure.
    McConnell PI, del Rio CL, Jacoby DB, Pavlicova M, Kwiatkowski P, Zawadzka A, Dinsmore JH, Astra L, Wisel S, Michler RE.
    J Thorac Cardiovasc Surg; 2005 Oct 20; 130(4):1001. PubMed ID: 16214511
    [Abstract] [Full Text] [Related]

  • 14. Improved diastolic function after myoblast transplantation in a model of ischemia-infarction.
    Pätilä T, Ikonen T, Kankuri E, Uutela A, Lommi J, Krogerus L, Salmenperä P, Bizik J, Lauerma K, Harjula A.
    Scand Cardiovasc J; 2009 Apr 20; 43(2):100-9. PubMed ID: 19016109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs.
    He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E, White D, Taylor DA, Wang J, Burkhoff D.
    J Heart Lung Transplant; 2005 Nov 20; 24(11):1940-9. PubMed ID: 16297802
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.
    Herreros J, Prósper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, Sánchez PL, Cañizo C, Rábago G, Martí-Climent JM, Hernández M, López-Holgado N, González-Santos JM, Martín-Luengo C, Alegria E.
    Eur Heart J; 2003 Nov 20; 24(22):2012-20. PubMed ID: 14613737
    [Abstract] [Full Text] [Related]

  • 20. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging.
    Ruan W, Pan CZ, Huang GQ, Li YL, Ge JB, Shu XH.
    Chin Med J (Engl); 2005 Jul 20; 118(14):1175-81. PubMed ID: 16117862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.